Ultrasonographic Muscles and Fascia Measurement With Myofascial Pain Syndrome

Investigation of the Diagnostic Effect of Ultrasonographic Measurement Values of Upper Back Muscles and Fascia in Patients With Myofascial Pain Syndrome

Pathologies in the trapezius muscle and rhomboid muscle are important in the course and treatment of the disease in patients with myofascial pain syndrome.

Study Overview

• Status: Completed
• Conditions: Myofascial Pain Syndrome
• Intervention / Treatment: Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia; Other: fascia injection

Detailed Description

In this study, the role of the thickness of these muscles and the shift during movement in the activity and diagnosis of the disease in myofascial pain syndrome will be investigated.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Bursa, Turkey, 16320
    • Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
  • Bursa
    • Nilüfer, Bursa, Turkey, 16110
      • Burcu Metin Ökmen

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 50 years (Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• 18-65 years old
• myofascial pain syndrome

Exclusion Criteria:

• Cervical radiculopathy
• Fibromyalgia
• Shoulder joint disease,
• Peripheral and central nervous system disease
• Polyneuropathy,
• Inflammatory rheumatic disease,
• Malignancy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Patients diagnosed with myofascial pain syndrome; Ultrasound measurements will be made while the upper back is at rest and during arm movements.	Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia; B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees; Other: fascia injection; Under ultrasound guidance, a local anesthetic and steroid mixture will be injected into the fascia between the trapezius muscle and the rhomboid muscle.
Active Comparator: Healthy volunteers; Ultrasound measurements will be made while the upper back is at rest and during arm movements.	Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia; B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Trapezius muscle and rhomboid muscle thickness	Trapezius and rhomboid muscle thickness and fascial thickness measurement will be made by ultrasonography at rest.	20 minute
fascial sliding	Measurements of the amount of slip measured during the movement of the fascial structures during shoulder and arm movements. ultrasonography M-mode measurements Arm from the shoulder joint, cervical lateral flexion, cervical anterior flexion, shoulder elevation	20 minute

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
VAS	visual analog scale (VAS) :for pain. 0: no pain at all, 10: worst pain imaginable	6 th month
NPDS	Neck and Disability Scale (NPDS): The 20-item Neck and Disability Scale is scored on a 10 cm visual analog scale and ranges from 0 to 5 points. The test aims to measure the impact of neck pain on quality of life, functionality, and disability.	6th month
SF-12	Short Form 12 (SF-12): The SF-12 form, which includes scales to assess physical (SF-12-PCS) and mental (SF-12-MCS) status, was created by taking 12 different items from 8 other titles of the SF-36, which is the extended version. Interpretation of Scores: Utilize the norm-based scoring system to interpret PCS and MCS scores, with a mean of 50 and a standard deviation of 10 in the general population. Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health.	6th month

Collaborators and Investigators

• Sponsor: Bursa Yüksek İhtisas Education and Research Hospital
• Investigators: Study Chair: Korgün Ökmen, Assoc. PhD., Bursa Yuksek Ihtisas Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2021
• Primary Completion (Actual): May 1, 2024
• Study Completion (Actual): August 1, 2024

Study Registration Dates

• First Submitted: April 27, 2022
• First Submitted That Met QC Criteria: April 30, 2022
• First Posted (Actual): May 4, 2022

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 5, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Nervous System Diseases; Muscular Diseases; Mental Disorders; Pathologic Processes; Neuromuscular Diseases; Rheumatic Diseases; Disease; Somatoform Disorders; Syndrome; Fibromyalgia; Myofascial Pain Syndromes
• Other Study ID Numbers: 2021/10-16

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No